Data at ASH, SABCS demonstrate commitment of Novartis R&D in advancing treatments for patients with cancer and rare …
December 3, 2010 by hrform3
Filed under Hair Loss Prevention
Data at ASH, SABCS demonstrate commitment of Novartis R&D in advancing treatments for patients with cancer and rare …
With more than 170 presentations focused on its marketed and pipeline compounds at key oncology medical congresses in December, Novartis continues to demonstrate progress of its innovative research and development efforts, collaboration with the scientific community and commitment to patients with cancer and rare diseases.
Read more on PR Newswire via Yahoo! Finance
